National Cancer Institute Home at the National Institutes of Health | www.cancer.gov

Photo of Antoinette Percy-Laurry View Publications

Antoinette Percy-Laurry

Public Health Analyst

Phone: (301) 594-8421
Email: percyl@mail.nih.gov

Areas of Expertise:

  • Cancer Control in Public Health
  • Health Disparities & Social Determinants of Health
  • Health Behavior & Health Education
  • Social Epidemiology

Ms. Percy-Laurry is a public health analyst in the Data Analysis and Interpretation Branch of the Surveillance Research Program within the National Cancer Institute (NCI). She has been Chair of the State Cancer Profiles committee since 2008 and manages their web site, which presents national, state, and county level data from the NCI and Centers for Disease Control and Prevention. She is also involved in health-disparities-related work and other projects that lead to the development and dissemination of surveillance data across different programs and agencies. This includes being a member of a multi-disciplinary research team that supports the use of the Health Disparities Calculator (HD*Calc) software. She also assists with the development and publication of technical manuals used by cancer registry professionals.

Ms. Percy-Laurry served on the data quality improvement team for the Surveillance, Epidemiology, and End Results (SEER) Program from 2004 to 2011. In 2008, she was commissioned into the U.S. Public Health Service Commissioned Corps as a Health Services Officer. From 2009-2010, she served as Chair of the Division of Cancer Control and Populations Sciences Health Disparities Interest Group Seminar Series, where she provided leadership to address cancer-related disparities.

Ms. Percy-Laurry received a Master of Science in Public Health from the University of Alabama at Birmingham with a specialization in health behavior and a Bachelor of Science in Biology at Oakwood University. She is currently working towards her Doctor of Public Health degree. Prior to joining NCI SEER, Ms. Percy-Laurry contributed to field studies and clinical trials such as the Women’s Health Initiative Program and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.